Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
November 11, 2025 20:40 ET Â | Source: Centessa Pharmaceuticals plc BOSTON and…
BPGbio Appoints John Dvor as Executive Vice President, Corporate Development
BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered,…
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Announces Elite Level Sponsorship of the 2025 American Nuclear Society Winter Conference & Expo
Oak Ridge, Tennessee, Nov. 11, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc.…
OSS to Demonstrate Best-In-Class High Performance Compute Portfolio at SC25
Company to showcase portfolio of ultra-dense, high-performance computing performance solutions for commercial…
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
November 10, 2025 21:56 ET Â | Source: Vor Biopharma BOSTON, Nov. 10,…
Canadian Red Cross sending emergency medical clinic to Jamaica
Humanitarian experts deploying to help people impacted by Hurricane Melissa November 10,…
Evidium Announces $22M Funding Close to Scale Computational Medical Knowledge
SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Evidium, a healthcare AI…
RUNSTACK Unveils Hypergraph Long-Term Memory for Agentic Systems
NORTH YORK, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- RUNSTACK Inc., a…
GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary…
GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025
Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in…